N H Hunt

Author PubWeight™ 89.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol 1987 2.91
2 Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun 1983 2.59
3 Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 1992 1.78
4 Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol 1987 1.69
5 Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol 1986 1.58
6 Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988 1.47
7 Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia 1997 1.32
8 Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 1998 1.32
9 Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol 2008 1.30
10 Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol 1988 1.27
11 Free radical-induced pathology. Med Res Rev 1985 1.26
12 Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol 1992 1.19
13 A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J 1999 1.17
14 Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol 1996 1.17
15 Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia 1996 1.14
16 Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol 1997 1.14
17 Conventional and experimental treatment of cerebral malaria. Int J Parasitol 2006 1.12
18 Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? Immunol Cell Biol 2001 1.12
19 Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney. J Endocrinol 1976 1.10
20 Oxygen-derived free radicals in the pathogenesis of parasitic disease. Adv Parasitol 1986 1.08
21 Possible mechanisms responsible for the increased ascorbic acid content of Plasmodium vinckei-infected mouse erythrocytes. Biochim Biophys Acta 1986 1.04
22 Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature 1976 1.03
23 Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Parasitology 1993 1.03
24 Is ischemia involved in the pathogenesis of murine cerebral malaria? Am J Pathol 2001 1.02
25 Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. Br J Cancer 1977 1.02
26 Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol 2001 1.00
27 ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001 1.00
28 Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Br J Exp Pathol 1989 0.99
29 Role of 3',5'-cyclic AMP in glucagon-induced stimulation of ruthenium red-insensitive calcium transport in an endoplasmic reticulum-rich fraction of rat liver. FEBS Lett 1980 0.98
30 Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochem Biophys Res Commun 1983 0.96
31 Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer 1977 0.96
32 Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia 1997 0.95
33 Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta 1997 0.91
34 Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids 2010 0.90
35 Cyclic nucleotide excretion in human malignancies. Clin Sci (Lond) 1980 0.90
36 Oxidative stress and protective mechanisms in erythrocytes in relation to Plasmodium vinckei load. Proc Natl Acad Sci U S A 1985 0.90
37 RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations. Biochim Biophys Acta 1980 0.89
38 Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue. Redox Rep 2000 0.89
39 Role of vasopressin in the mitotic response of rat bone marrow cells to haemorrhage. J Endocrinol 1977 0.89
40 Redox metabolism of vitamin C in blood of normal and malaria-infected mice. Biochim Biophys Acta 1993 0.89
41 Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun 1984 0.89
42 Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology 1995 0.88
43 Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun 2005 0.88
44 Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis 1999 0.88
45 Development of the "activated" high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle. Magn Reson Med 1990 0.87
46 Fas and perforin contribute to the pathogenesis of murine cerebral malaria. Redox Rep 1999 0.87
47 Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency. Br J Haematol 1984 0.87
48 Detection of short-chain carbonyl products of lipid peroxidation from malaria-parasite (Plasmodium vinckei)-infected red blood cells exposed to oxidative stress. Biochem J 1988 0.86
49 Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier. Am J Pathol 2000 0.86
50 Toxicity of certain products of lipid peroxidation to the human malaria parasite Plasmodium falciparum. Biochem Pharmacol 1987 0.86
51 NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev Immunogenet 2000 0.86
52 The intracellular oxidation of 2',7'-dichlorofluorescin in murine T lymphocytes. Free Radic Biol Med 2001 0.86
53 Vitamin C redox reactions in blood of normal and malaria-infected mice studied with isoascorbate as a nonisotopic marker. Free Radic Biol Med 1995 0.85
54 Radical-mediated damage to parasites and erythrocytes in Plasmodium vinckei infected mice after injection of t-butyl hydroperoxide. Clin Exp Immunol 1984 0.85
55 Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochim Biophys Acta 1995 0.85
56 CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Allergy 2009 0.84
57 Cyclic nucleotide metabolism and reactive oxygen production by macrophages. Biochem Biophys Res Commun 1980 0.84
58 Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications. J Infect Dis 1997 0.84
59 Flavin analogs with antimalarial activity as glutathione reductase inhibitors. Biochem Pharmacol 1990 0.83
60 Response of human and chick kidney adenylate cyclase to biologically active synthetic fragments of human parathyroid hormone. Biochem Biophys Res Commun 1978 0.83
61 Protection of vitamin E from oxidation by increased ascorbic acid content within Plasmodium vinckei-infected erythrocytes. Biochim Biophys Acta 1986 0.82
62 Antioxidants in plasma from mice infected with Plasmodium vinckei. Biochem Biophys Res Commun 1986 0.82
63 Rat osteogenic sarcoma cells: isolation and effects of hormones on the production of cyclic AMP and cyclic GMP. Endocrinology 1977 0.81
64 Membranes from a transplantable osteogenic sarcoma responsive to parathyroid hormone and prostaglandins: regulation of adenylate cyclase and of hormone metabolism. J Endocrinol 1978 0.81
65 Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J Lipid Res 1998 0.81
66 Free oxygen radicals in malaria. Lancet 1983 0.80
67 Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone. Eur J Biochem 1984 0.80
68 Hormone receptors and cyclic nucleotide metabolism in cancer cells. Clin Endocrinol (Oxf) 1976 0.80
69 Adenylate cyclase activity of renal cortical carcinoma and its relation to histology and ultrastructure. Cancer Res 1978 0.80
70 Proceedings: Effects of guanyl nucleotides upon basal and parathyroid hormone-stimulated chick kidney adenylate cyclase. J Endocrinol 1975 0.79
71 Enzymatic deacylation of mono- and dibutyryl derivatives of cyclic adenosine 3',5'-monophosphate by extracts of rat tissues. J Biol Chem 1972 0.79
72 Lipids from Plasmodium vinckei-infected erythrocytes and their susceptibility to oxidative damage. Lipids 1987 0.79
73 Studies in vivo on the effects of parathyroid hormone upon kidney cyclic adenosine 3',5'-monophosphate content using rapid tissue fixation by microwave irradiation. Horm Metab Res 1976 0.79
74 Oxidative signalling and gene expression during lymphocyte activation. Biochim Biophys Acta 1996 0.79
75 Inhibition of drug-naive and -resistant leukemia cell proliferation by low molecular weight thiols. Biochem Pharmacol 1998 0.79
76 Use of fixed cells in cell contact-dependent cytotoxicity assays for TNF: a cautionary report. J Immunol Methods 1999 0.78
77 Reactive oxygen production, arachidonate metabolism and cyclic AMP in macrophages. Biochem Biophys Res Commun 1983 0.78
78 Radiation induced osteogenic sarcoma in the rat as a model of hormone-responsive differentiated cancer. Lab Anim Sci 1977 0.78
79 Increased production of arachidonate metabolites by peritoneal cells of mice infected with Plasmodium vinckei vinckei. Aust J Exp Biol Med Sci 1986 0.78
80 Activation of cyclic AMP-dependent protein kinase in macrophages. Biochem Biophys Res Commun 1984 0.78
81 In vitro effects of three iron chelators on mitogen-activated lymphocytes: identification of differences in their mechanisms of action. Int J Immunopharmacol 1992 0.78
82 Soluble TNF-alpha receptors bind and neutralize over-expressed transmembrane TNF-alpha on macrophages, but do not inhibit its processing. J Leukoc Biol 1999 0.77
83 Antimalarial action of flavin analogues seems not be due to inhibition of glutathione reductase of host erythrocytes. Biochem Pharmacol 1990 0.77
84 Antimalarial activity of a riboflavin analog against Plasmodium vinckei in vivo and Plasmodium falciparum in vitro. Am J Trop Med Hyg 1987 0.77
85 Flavins as potential antimalarials. 1. 10-(Halophenyl)-3-methylflavins. J Med Chem 1988 0.77
86 Separation of tumor necrosis factor alpha isoforms by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1997 0.77
87 States of activation of chick kidney adenylate cyclase induced by parathyroid hormone and guanyl nucleotides. J Endocrinol 1977 0.76
88 Thiol-bearing compounds selectively inhibit protein kinase C-dependent oxidative events and proliferation in human T cells. Biochim Biophys Acta 1994 0.76
89 Characterization of beta-adrenergic receptor linked to adenylate cyclase in a human cancer cell line (COLO 16). Clin Sci Mol Med 1978 0.76
90 Needle in a haystack: microdissecting the proteome of a tissue. Amino Acids 2004 0.76
91 Role of immune mediators in the pathology of experimental murine cerebral malaria. Redox Rep 1999 0.76
92 Iron chelators and lymphocyte proliferation. Immunology 1991 0.75
93 Modulation of T cells by cyclic AMP in murine influenza virus infection. I. In vitro inhibition of cytotoxic T lymphocytes by exogenous cyclic AMP analogues and by agents which increase intracellular cyclic AMP concentrations. Immunopharmacology 1987 0.75
94 Erythropoietin-induced changes in plasma calcium and bone marrow mitosis in the rat. J Endocrinol 1973 0.75
95 Studies on the role of cyclic GMP in the control of human platelet function. Biochem Soc Trans 1980 0.75
96 Proceedings: In-vivo studies of parathyroid hormone action on chick kidney cyclic adenosine 3':5'-monophosphate content using rapid tissue fixation. J Endocrinol 1976 0.75
97 Proceedings: hormone-responsive adenylate cyclase in a transplantable osteogenic sarcoma in the rat. J Endocrinol 1976 0.75
98 Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells. Eur J Biochem 1986 0.75
99 Bleomycin-detectable iron in plasma from Plasmodium vinckei vinckei-infected mice. FEBS Lett 1986 0.75
100 Glycogen synthesis in resident and thioglycollate-elicited rat peritoneal exudate cells. Int J Biochem 1983 0.75
101 Cyclic nucleotide metabolism in tumours. Aust N Z J Med 1979 0.75
102 Proceedings: Stimulation of mitosis in rat bone marrow cells by antidiuretic hormone after haemorrhage. J Endocrinol 1975 0.75
103 Dichloroacetate (DCA) reduces brain lactate but increases brain glutamine in experimental cerebral malaria: a 1H-NMR study. Redox Rep 2000 0.75
104 Rapid changes in the activities of the enzymes of cyclic AMP metabolism after addition of A23187 to macrophages. Biochem Biophys Res Commun 1981 0.75
105 Proceedings: Interactions of guanylnucleotides, parathyroid hormone and analogues with chick kidney adenylate cyclase. J Physiol 1976 0.75
106 Prostaglandins and breast cancer. Lancet 1977 0.75
107 The effect of antioxidants on global and cytokine gene expression in T lymphocytes. Redox Rep 1999 0.75
108 Proceedings: Prostaglandins as possible mediators of tumour-induced bone resorption. J Physiol 1976 0.75
109 Flavins as potential antimalarials. 2. 3-Methyl-10-(substituted-phenyl) flavins. J Med Chem 1991 0.75
110 Cyclic-AMP inhibits neither A23187-stimulated [14C]-arachidonic acid release from prelabelled lipids nor phospholipase A2 activity in resident rat peritoneal macrophages. Biochem Int 1990 0.75
111 Reactive-oxygen formation and its relationship to prostaglandin and cyclic AMP production by zymosan-treated rat peritoneal macrophages. Mol Immunol 1985 0.75
112 Prostaglandin-stimulated cyclic AMP production in isolated rat osteogenic sarcoma cells [proceedings]. J Endocrinol 1977 0.75
113 NRK-dependent phosphorylation of NAB-3: involvement in ACRK-13-mediated PUFFL activation or NEE-JRK activation of ACRO. Redox Rep 2001 0.75
114 Pre-incubation of chick kidney tubules and particulate preparations with parathyroid hormone: effects on subsequent responsiveness of adenylate cyclase to parathyroid hormone and 5'-guanylylimidodiphosphate [proceedings]. J Endocrinol 1977 0.75
115 Phagocyte-derived reactive oxygen species and the immunology and pathology of murine malaria. Redox Rep 2001 0.75
116 Adenylate cyclase in plasma membranes purified from rat osteogenic sarcoma. Biochem Soc Trans 1977 0.75
117 Calcium and the control of circadian mitotic activity in rat bone marrow and thymus. J Endocrinol 1974 0.75
118 Identification and quantitation of adenosine-3':5'-cyclic monophosphate in plants using gas chromatography-mass spectrometry and high-performance liquid chromatography. Planta 1981 0.75
119 Isolation and hormone-responsiveness of intact cells from a transplantable osteogenic sarcoma in the rat. Biochem Soc Trans 1976 0.75